A new advanced artificial intelligence (AI) algorithm more accurately model how genes associated with specific autoimmune diseases are expressed and regulated and to identify additional genes of risk.

HERSHEY, Pa. — A new advanced artificial intelligence (AI) algorithm may lead to better — and earlier — predictions and novel therapies for autoimmune diseases, which involve the immune system ...

Autoimmune rheumatic diseases (ARDs) represent a diverse group of conditions in which the immune system mistakenly targets the body’s own tissues, often affecting the musculoskeletal system and ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced the launch of a new program specifically geared towards using ...

New RNA-based algorithm is now available with the xR assay “This program is truly the intersection of all three of our business units – genomics, AI applications, and data – leveraging our deep ...

Thermo Fisher Scientific, Inc. TMO announced the receipt of the FDA clearance for EliA RNA Polymerase III and EliA Rib-P blood tests intended to diagnose systemic sclerosis (SSc) and systemic lupus ...

The MosaiQ solution is a next-generation IVD solution for autoimmune diseases, allergies and beyond. The multiplexed, fully automated planar microarray platform enables syndromic testing for complex ...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, recently launched aPAP ClearPath™, a new ...

One growth driver includes the rising prevalence of autoimmune diseases. The global autoimmune disease testing market is estimated to reach $12.1b by 2033 at a compound annual growth rate of 8.6%, ...